There are law firms in which Carrie Garber Siegrist, a senior associate in the Washington, D.C., office of Goodwin Procter, might have had to be secretive about her diagnosis of attention-deficit/hyperactivity disorder, also known as ADHD. But at Goodwin Procter, Garber Siegrist says, she feels embraced and supported.

CONFERENCE REPORTER: “ADHD is something that has historically been underrecognized, and even unrecognized, in adults, and because of that, there are a lot of myths that surround ADHD in adults.” In this Mental Health Minute, Shafi Lodhi, MD, a neuropsychiatrist based in California, gives Psychiatric Times® a preview of “ADHD in Previously Undiagnosed Adults: A…

This 2024 APA Annual Meeting poster covered a literature review on the relationship between stimulant use and failure to thrive in pediatric patients with ADHD.

[Excerpt] The “lost” mental health generation primarily comprises individuals who were children before the late 20th century, a period when awareness and understanding of ASD, ADHD, and bipolar disorder were significantly less than today and diagnostic criteria were not precise — or they were non-existent (e.g., the term “minimal brain dysfunction” was commonly substituted for…

Stimulant use for attention-deficit/hyperactivity disorder (ADHD) could increase risk of heart damage in young adults, according to recent results published in the Journal of the American College of Cardiology.

The AAP, the American Academy of Child and Adolescent Psychiatry (AACAP) and Children’s Hospital Association (CHA) are calling on federal officials to lead discussions and identify solutions for ongoing shortages of stimulants and other medications that impact child health. A letter sent by the three organizations to the U.S. Department of Health and Human Services…

A new study published in the journal European Psychiatry has shed light on an unconventional approach to managing symptoms associated with Attention-Deficit Hyperactivity Disorder (ADHD). The findings suggest that small, repeated doses of substances like psilocybin and lysergic acid diethylamide (LSD) could potentially help reduce ADHD symptoms and enhance some aspects of emotion regulation. These findings could…

Do you ever delay putting away clean laundry or unworn outfits from a vacation and instead keep those clothes in a pile on the floor or draped over a chair for many days on end? What about items you’ve only worn once and don’t want to wash but also don’t want to return to your…

In the early 2000s, Gloria Mark noticed she was having trouble paying attention to any single screen. Anecdotally, she knew others were feeling the same way. As a psychologist and scientist, she decided to test it – are computers impacting our attention spans?

Depression and neurodivergent have similar symptoms, but are they the same? Explore the link between neurodivergence and depression here.

Tris Pharma Inc has announced a licensing agreement with Braingaze Ltd and the establishment of Tris Digital Health. Tris Digital Health will concentrate on developing and distributing digital diagnostic and therapeutic products for the treatment of attention-deficit/hyperactivity disorder (ADHD) and other neurological health disorders.1

Psychiatric disorders such as anxiety and depression have gradually become a major public health concern with 1 of every 8 individuals worldwide experiencing a mental disorder.1,2 Various and individual psychological, biological, and environmental risk factors can influence brain structure and function and contribute to the development of mental health disorders.3,4